This site is intended for health professionals only
Tuesday 22 January 2019
Share |

Latest News

NICE recommends Verzenios with an aromatase inhibitor (AI) to treat metastatic breast cancer

Monday 21st January 2019

The National Institute of health and Care Excellence (NICE) has recommended Verzenios (abemaciclib) in combination with an aromatase inhibitor (AI) to treat metastatic breast cancer.
Eli Lilly and Company announced on 18 January that the drug is recommended by NICE within its marketing authorisation as an option for treating locally advanced or metastatic, hormone receptor- positive, human epidermal growth factor receptor 2 (HER2)-negative breast cancer as first endocrine-...

You are leaving

You are currently leaving the Nursing in Practice site. Are you sure you want to proceed?


Respect for nurses: Sign up to our e-petition TODAY

The Nursing in Practice Respect campaign is now live! Over the coming months, we're set to highlight the vital contribution and efforts of primary care and community care nurses throughout the UK.

As part of our campaign, Nursing in Practice is looking to call on parliament to set up a debate to celebrate the vital work that you do.



Calling all primary care nurses! 'Like' our Nursing in Practice Facebook page to enter our free draw to win a £25 M&S voucher